|
⚲
|
| Keyboard |
| Rasdal Andrew P
✚
|
|
|---|---|
| CIK # | 0001323238 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001323238] | |
| 4 | [0001323238] | |
| SC 13G | [0001323238] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Rasdal Andrew P | Obalon Therapeutics Inc | [2018-02-14] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Obalon Therapeutics Inc | |
| Rasdal Andrew P |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Obalon Therapeutics Inc OBLN
Stock Option (Right to Buy) · derivative
|
2020-06-23 | Grant | 165,135 | $0.00 | |
|
Obalon Therapeutics Inc OBLN
Stock Option · derivative
|
2020-06-23 | Grant | 52,865 | $0.00 | |
|
Obalon Therapeutics Inc OBLN
Warrants (Right to Buy) · derivative
|
2019-08-06 | Buy | 9,375 | $0.00 | |
|
Obalon Therapeutics Inc OBLN
Common Stock
|
2019-08-06 | Buy | 12,500 | $4.00 | 50,000 |
|
Obalon Therapeutics Inc OBLN
Common Stock (Restricted Stock Units)
|
2019-01-02 | Grant | 86,957 | $0.00 | |
|
Obalon Therapeutics Inc OBLN
Common Stock
|
2018-08-23 | Grant | 109,890 | $1.82 | 200,000 |
|
Obalon Therapeutics Inc OBLN
Common Stock
|
2018-04-30 | Grant | 2,987 | $3.27 | 9,767 |
|
Obalon Therapeutics Inc OBLN
Stock Option (Right to Buy) · derivative
|
2018-01-02 | Grant | 300,000 | $0.00 | |
|
Obalon Therapeutics Inc OBLN
Common Stock
|
2017-10-31 | Grant | 808 | $7.17 | 5,793 |
|
Obalon Therapeutics Inc OBLN
Common Stock
|
2017-04-30 | Grant | 2,768 | $9.03 | 24,995 |
|
Obalon Therapeutics Inc OBLN
Stock Option (right to buy) · derivative
|
2016-11-09 | Grant | 300,000 | $0.00 |